论文部分内容阅读
Utilization of mesenchymal stromal cells (MSCs) forthe treatment of Crohn's disease and ulcerative colitisis of translational interest. Safety of MSC therapy hasbeen well demonstrated in early phase clinical trialsbut efficacy in randomized clinical trial